Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Parexel Connects to Exostar’s Life Sciences Cloud Collaboration Platform

Published: Tuesday, March 11, 2014
Last Updated: Tuesday, March 11, 2014
Bookmark and Share
Clinical Research Organization Joins Growing Community to More Efficiently and Effectively Partner with its Customers

Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, has announced that Parexel is the latest clinical research organization (CRO) to become a member of Exostar’s rapidly growing Life Sciences community.  More than 500 pharmaceutical manufacturers, investigators, CROs, and other organizations and over 10,000 individuals in nearly 50 countries on six continents are collaborating productively and securely by connecting to Exostar’s cloud-based Life Sciences Identity Hub.

Parexel provides a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries.  The company’s expertise spans the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology and clinical trials management.

The Exostar Life Sciences Identity Hub reduces the cost and resource burdens of collaborating with external partners through a connect-once architecture for systems and applications.  Because the cloud-based solution is delivered as-a-Service, participants benefit from streamlined and standardized organization and user provisioning processes.  New community members can be working productively with their partners within days instead of weeks or months.

Organizations like Parexel retain administrative responsibility for their assets, including identifying valid users and their permissions and privileges.  Exostar’s Secure Access Manager (SAM) provides the identity and access management functionality to ensure intellectual property and sensitive data are protected at all times.  SAM validates identities through strong authentication and enforces access rules established by asset owners.  Parexel is further raising its employees’ efficiencies through SAM’s Enterprise Access Gateway (EAG) feature.  EAG lets individuals use their existing credentials to access the partner applications to which they are entitled, offering a true single sign-on experience.

“Parexel is committed to providing solutions that help its customers expedite time-to-market and achieve peak market penetration,” said Tom Johnson, Exostar’s Senior Director of Security and Collaboration Solutions for Life Sciences.  “Our community allows them to more effectively achieve these objectives by creating a connected, integrated environment where intelligence can be shared seamlessly and securely.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exostar’s Life Sciences Cloud Collaboration Platform Exceeds Growth Objectives
Life Sciences Identity Hub Tops 500 Organizations and 10,000 Users in First Year
Friday, February 21, 2014
Scientific News
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!